Bd statement on supplier issue impacting bd bactec™ blood culture vials

Company committed to support global health and customers bd taking all available measures to mitigate supplier issue franklin lakes, n.j. , july 10, 2024  /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today issued the following statement related to a u.s. fda letter to health care providers regarding the supply of blood culture vials: nikos pavlidis, worldwide president of bd diagnostic solutions said, "bd is experiencing reduced availability of blood culture vials from our supplier.
BDX Ratings Summary
BDX Quant Ranking